Literature DB >> 25485177

Regulated Expression Systems for Mycobacteria and Their Applications.

Dirk Schnappinger1, Sabine Ehrt2.   

Abstract

For bacterial model organisms like Escherichia coli and Bacillus subtilis genetic tools to experimentally manipulate the activity of individual genes existed for decades. But for genetically less tractable yet medically important bacteria such as M. tuberculosis such tools have rarely been available. More recently several groups developed genetic switches that function efficiently in M. tuberculosis and other mycobacteria. Together these systems utilize six different transcription factors, eight different regulated promoters, and three different regulatory principles. Here we describe their design features, review their main applications, and discuss advantages and disadvantages of regulating transcription, translation, or protein stability for controlling gene activities in bacteria.

Entities:  

Year:  2014        PMID: 25485177      PMCID: PMC4254785          DOI: 10.1128/microbiolspec.MGM2-0018-2013

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  118 in total

1.  Engineering controllable protein degradation.

Authors:  Kathleen E McGinness; Tania A Baker; Robert T Sauer
Journal:  Mol Cell       Date:  2006-06-09       Impact factor: 17.970

2.  Mycobacterial UvrD1 is a Ku-dependent DNA helicase that plays a role in multiple DNA repair events, including double-strand break repair.

Authors:  Krishna Murari Sinha; Nicolas C Stephanou; Feng Gao; Michael S Glickman; Stewart Shuman
Journal:  J Biol Chem       Date:  2007-03-20       Impact factor: 5.157

3.  Pristinamycin-inducible gene regulation in mycobacteria.

Authors:  Francesca Forti; Andrea Crosta; Daniela Ghisotti
Journal:  J Biotechnol       Date:  2009-02-13       Impact factor: 3.307

4.  Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis.

Authors:  Benjamin P Duckworth; Todd W Geders; Divya Tiwari; Helena I Boshoff; Paul A Sibbald; Clifton E Barry; Dirk Schnappinger; Barry C Finzel; Courtney C Aldrich
Journal:  Chem Biol       Date:  2011-11-23

5.  Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatis.

Authors:  Paul Carroll; D G Niranjala Muttucumaru; Tanya Parish
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

6.  Platensimycin is a selective FabF inhibitor with potent antibiotic properties.

Authors:  Jun Wang; Stephen M Soisson; Katherine Young; Wesley Shoop; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Gopalakrishnan Parthasarathy; Yui S Tang; Richard Cummings; Sookhee Ha; Karen Dorso; Mary Motyl; Hiranthi Jayasuriya; John Ondeyka; Kithsiri Herath; Chaowei Zhang; Lorraine Hernandez; John Allocco; Angela Basilio; José R Tormo; Olga Genilloud; Francisca Vicente; Fernando Pelaez; Lawrence Colwell; Sang Ho Lee; Bruce Michael; Thomas Felcetto; Charles Gill; Lynn L Silver; Jeffery D Hermes; Ken Bartizal; John Barrett; Dennis Schmatz; Joseph W Becker; Doris Cully; Sheo B Singh
Journal:  Nature       Date:  2006-05-18       Impact factor: 49.962

7.  Identification of mycobacterial sigma factor binding sites by chromatin immunoprecipitation assays.

Authors:  Sébastien Rodrigue; Joëlle Brodeur; Pierre-Etienne Jacques; Alain L Gervais; Ryszard Brzezinski; Luc Gaudreau
Journal:  J Bacteriol       Date:  2006-12-08       Impact factor: 3.490

8.  The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization.

Authors:  Sabine Daugelat; Jane Kowall; Jens Mattow; Dirk Bumann; Ralf Winter; Robert Hurwitz; Stefan H E Kaufmann
Journal:  Microbes Infect       Date:  2003-10       Impact factor: 2.700

9.  Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.

Authors:  Jun Wang; Srinivas Kodali; Sang Ho Lee; Andrew Galgoci; Ronald Painter; Karen Dorso; Fred Racine; Mary Motyl; Lorraine Hernandez; Elizabeth Tinney; Steven L Colletti; Kithsiri Herath; Richard Cummings; Oscar Salazar; Ignacio González; Angela Basilio; Francisca Vicente; Olga Genilloud; Fernando Pelaez; Hiranthi Jayasuriya; Katherine Young; Doris F Cully; Sheo B Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

10.  Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties.

Authors:  Theresa Wilson; Geoffrey W de Lisle; Jovita A Marcinkeviciene; John S Blanchardand; Desmond M Collins
Journal:  Microbiology (Reading)       Date:  1998-10       Impact factor: 2.777

View more
  2 in total

Review 1.  Inhibiting DosRST as a new approach to tuberculosis therapy.

Authors:  Huiqing Zheng; Robert B Abramovitch
Journal:  Future Med Chem       Date:  2020-02-13       Impact factor: 3.808

Review 2.  Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis.

Authors:  Reginaldo G Bastos; Heba F Alzan; Vignesh A Rathinasamy; Brian M Cooke; Odir A Dellagostin; Raúl G Barletta; Carlos E Suarez
Journal:  Vaccines (Basel)       Date:  2022-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.